From: Assessing survival time of heart failure patients: using Bayesian approach
Covariates | Categories | Pmean | Sd | Median | Credible Interval | Mode | Kld |
---|---|---|---|---|---|---|---|
Intercept | 4.953 | 0.221 | 4.945 | [4.541, 5.409]* | 4.929 | 0 | |
Age | ≤ 49–65 | Ref | |||||
49–65 | −0.258 | 0.115 | −0.256 | [−0.488, −0.036]* | −0.253 | 0 | |
≥ 65 | −0.336 | 0.110 | −0.335 | [−0.557, −0.125]* | −0.331 | 0 | |
Hypertension | No | Ref | |||||
Yes | −0.301 | 0.076 | −0.300 | [−0.452, −0.153]* | −0.299 | 0 | |
CKD | No | Ref | |||||
Yes | −0.389 | 0.075 | −0.388 | [−0.537, −0.244]* | −0.387 | 0 | |
Etiology of Heart failure | IHD | Ref | |||||
RVHD | −0.302 | 0.116 | −0.302 | [−0.533, −0.076]* | −0.300 | 0 | |
Cardiomyopathy | −0.158 | 0.113 | −0.158 | [−0.382, 0.063] | −0.157 | 0 | |
HDD | −0.258 | 0.115 | −0.257 | [−0.486, −0.035]* | −0.255 | 0 | |
Others | −0.381 | 0.160 | −0.381 | [−0.693, −0.066]* | −0.382 | 0 | |
Smoking cigarette | No | Ref | |||||
Yes | −0.156 | 0.073 | −0.155 | [−0.300, −0.014]* | −0.154 | 0 | |
Stages of Heart failure | I | Ref | |||||
II | −0.400 | 0.190 | −0.397 | [−0.782, −0.038]* | −0.389 | 0 | |
III | −0.423 | 0.176 | −0.419 | [−0.781, −0.090]* | −0.410 | 0 | |
IV | −0.506 | 0.173 | −0.501 | [−0.857, −0.180]* | −0.492 | 0 | |
Diabetes mellitus | Not | Ref | |||||
Type I | −0.232 | 0.10 | 0.231 | [−0.431, −0.036]* | −0.230 | 0 | |
Type II | −0.422 | 0.086 | −0.421 | [−0.593, −0.255]* | −0.419 | 0 | |
Anemia | No | Ref | |||||
Yes | −0.154 | 0.072 | −0.153 | [−0.298, −0.013]* | −0.152 | 0 | |
Tau parameter | For log-normal | 4.30 | 0.497 | 4.28 | [3.38, 5.33]* | 4.24 | – |